For reviewers
Peer Review Model
Pharmaceutical Sciences and Health Products uses double-blind external peer review. Reviewer identities are not disclosed to authors. Suitable manuscripts are evaluated by at least two independent external reviewers. Recommendations are advisory; the handling editor and, where required, the Editor-in-Chief make the final decision.
Double-blind external review
- Reviewer identities are not disclosed to authors.
- The Editorial Office manages reviewer independence and conflicts of interest.
- Reviewers assess the manuscript and relevant supplementary materials supplied through the secure portal.
- Reviewer reports are sent to authors without reviewer names and are not routinely published.
- Reviews are not signed in correspondence with authors.
Number and independence of reviewers
Every scholarly manuscript accepted by PSHP must first receive reports from at least two independent external reviewers, except editorial material that the journal explicitly designates for editorial assessment only. An additional reviewer may be invited when reports conflict, specialist statistical or information-retrieval expertise is required, or integrity concerns need further assessment.
Supplementary materials
Protocols, reporting checklists, datasets, analytical validation, spectra or chromatograms, process documentation, search strategies, model files, code and other supplementary material form part of the review record when submitted and should be examined when relevant to the reviewer’s expertise.
Materials not normally sent for external review
Corrections, retractions, expressions of concern, publisher notices, editorial notices and administrative announcements may undergo editorial assessment rather than ordinary external review. The published item will identify its nature.
Editorial decision
The recommendation of a reviewer does not constitute the final decision. The handling editor evaluates all reports, the manuscript and journal policies. The Editor-in-Chief may review difficult, disputed or integrity-related cases.